Appendix D. CENTER / FDA’s HQ / FDA’s Headquarters / /
IndustryTerm
animal drug applications / telecommunications / manufacturing facilities / time reporting systems / finance / information technology services / /
Organization
Legislation office of Policy / Immediate Office / Division of Cost Determination Management / Women’s Health Office / office of Shared Services / office of Medical Products and Tobacco / office of Finance / Center for Devices and Radiological Health / National Center for Toxicological Research / office of Women / office of Global Regulatory Operations and Policy / office of Regulatory Affairs / Commissioner Office / External Affairs Office / Center for Tobacco Products / Operations office of Foods / Executive Secretariat Office / FDA / ORA / Policy and Planning Office / National Center / General Services Administration / Food Safety / Center for Drug Evaluation and Research / Department of Health and Human Services / Center for Veterinary Medicine / office of the Secretary / Center for Biologics Evaluation and Research / CVM / Chief Counsel office of Minority Health FY / Appendix D. CENTER-WIDE AND AGENCY / /
Position
Chief Scientist / Counselor / President / Commissioner / Agency General / Secretary / /
APPENDIX E DEVELOPMENT OF COSTS FOR THE PROCESS FOR THE REVIEW OF ANIMAL DRUG APPLICATIONS GENERAL METHODOLOGY The costs associated with the process for the review of animal drug applications are based on obligations rec